Search Results - "Klein, Molly E"

Histologic Features of Hysterectomy Specimens From Female-Male Transgender Individuals by Khalifa, Mahmoud A, Toyama, Aimi, Klein, Molly E, Santiago, Victor

“…Histologic changes in the female genital tract after prolonged androgen stimulation have been described in the past. However, these changes have not been…”
Get full text

High False-Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance Study by DABBS, David J, KLEIN, Molly E, MOHSIN, Syed K, TUBBS, Raymond R, YONGLI SHUAI, BHARGAVA, Rohit

“…HER2 (ERBB2) status is an important prognostic and predictive marker in breast carcinoma. In recent years, Genomic Health (GHI), purveyors of the Oncotype DX…”
Get full text

Microscopic Features of Vaginectomy Specimens from Transgender Patients by Dasaraju, Sandhyarani, Klein, Molly E, Murugan, Paari, Farooqui, Mariya, Khalifa, Mahmoud A

“…Abstract Objectives We aimed to better understand the histologic changes in vaginectomy specimens in transgender and gender-diverse (TGD) individuals after…”
Get full text

Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis by Klein, Molly E, Dabbs, David J, Shuai, Yongli, Brufsky, Adam M, Jankowitz, Rachel, Puhalla, Shannon L, Bhargava, Rohit

“…Oncotype DX is a commercial assay frequently used for making chemotherapy decisions in estrogen receptor (ER)-positive breast cancers. The result is reported…”
Get full text

Histopathologic Features of Breast Tissue From Transgender Men and Their Associations With Androgen Therapy by Wolters, Emily A, Rabe, Kimmie E, Siegel, Lianne, Butts, Jessica, Klein, Molly E

“…Abstract Objectives To assess the histopathologic features of breast tissue of transgender men (TM) undergoing gender-affirming bilateral mastectomies in…”
Get full text

Implementation of endometrial cancer molecular subtyping into a hybrid community-academic practice by Ferreira, Elizabeth O, Schefter, Alexandra M, Brustad, Abby, Klein, Molly E, Khalifa, Mahmoud A, Winterhoff, Boris, Nelson, Andrew C

“…We sought to confirm utility of our institution's modified Proactive Molecular Risk Classifier for Endometrial Cancer protocol in our daily practice, which…”
Get full text

Sentinel Nodal Metastasis Detection in Endometrial Carcinoma With Microcystic, Elongated, and Fragmented Pattern by Cytokeratin Immunostaining: A Recommendation for Routine Processing Protocols by Rabe, Kimmie M, Klein, Molly E, Ghatak, Sayak, Stout, Irina, Schefter, Alexandra, Erickson, Britt K, Khalifa, Mahmoud A

“…Objectives: The microcystic, elongated, and fragmented (MELF) pattern of myoinvasion in endometrial carcinoma (EC) is associated with an increased risk of…”
Get full text

Real-Time Intraoperative Consultation Reporting in the Electronic Health Record: An Innovative Method to Enhance Communication and Promote Patient Safety by Klein, Molly E, Rudolf, Joseph W, Tarbunova, Maryna, Jorden, Tanya, Clark, Susanna R, Khalifa, Mahmoud A

“…Objectives: We sought to make pathologists' intraoperative consultation (IOC) results immediately available to the surgical team, other clinicians, and…”
Get full text

Sentinel Nodal Metastasis Detection in Endometrial Carcinoma With Microcystic, Elongated, and Fragmented (MELF) Pattern by Cytokeratin Immunostaining by Rabe, Kimmie M, Klein, Molly E, Ghatak, Sayak, Stout, Irina, Schefter, Alexandra, Erickson, Britt K, Khalifa, Mahmoud A

“…Abstract Objectives The microcystic, elongated, and fragmented (MELF) pattern of myoinvasion in endometrial carcinoma (EC) is associated with an increased risk…”
Get full text

Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy by Sahoo, Sunati, Krings, Gregor, Chen, Yunn-Yi, Carter, Jodi M, Chen, Beiyun, Guo, Hua, Hibshoosh, Hanina, Reisenbichler, Emily, Fan, Fang, Wei, Shi, Khazai, Laila, Balassanian, Ronald, Klein, Molly E, Shad, Sonal, Venters, Sara J, Borowsky, Alexander D, Symmans, W Fraser, Ocal, I Tolgay

“…Neoadjuvant systemic therapy refers to the use of systemic agent(s) for malignancy prior to surgical treatment and has recently emerged as an option for most…”
Get full text

Adenomyosis As a Confounder to Accurate Endometrial Cancer Staging by Khalifa, Mahmoud A., Atri, Mostafa, Klein, Molly E., Ghatak, Sayak, Murugan, Paari

“…The coexistence of endometrial adenocarcinoma and adenomyosis in the same uterus is a common phenomenon. In many of such affected patients foci of adenomyosis…”
Get full text

Immunohistochemistry and immunofluorescence utilization audit by subspecialty in an academic setting: A step toward stewardship by Khalifa, Mahmoud A., Gagner, Brooke, Chen, Liam, Murugan, Paari, Klein, Molly E., Racila, Emilian, Amin, Khalid, Miller, Daniel, Stewart, Jimmie, Ding, Yanli, Farooqui, Mariya, Dasaraju, Sandhyarani, Adeyi, Oyedele A.

“…There are immunohistochemistry (IHC) and immunofluorescence (IF) panels described in the literature and established by personal and institutional experiences…”
Get full text

Mixed neuroendocrine/Non-neuroendocrine neoplasm (MiNEN) of gastrointestinal lineage arising in an ovarian mature cystic teratoma by Dasaraju, Sandhyarani, Amin, Khalid, Klein, Molly E., Rivard, Colleen, Mattson, Jordan, Davidson, Sarah, Khalifa, Mahmoud A.

“…•Mixed neuroendocrine/non-neuroendocrine neoplasm (MiNEN) of gastrointestinal lineage arising in an ovarian mature cystic teratoma is extremely rare.•It is…”
Get full text

Assessment of the Intraoperative Consultation Service Rendered by General Pathologists in a Scenario Where a Well-Defined Decision Algorithm Is Followed by Khalifa, Mahmoud A., Salama, Sherine, Vogel, Rachel I., Klein, Molly E., Richter, James, Pulver, Tanya, Mullany, Sally A., Winterhoff, Boris

“…Abstract Objectives: Intraoperative consultation (IOC) remains an area of general practice even within subspecialized pathology departments. This study…”
Get full text

Selective breast/gynecologic pathology fellowship training in the United States: Experience of program directors by Desouki, Mohamed Mokhtar, Hagemann, Ian S., Khoury, Thaer, Fadare, Oluwole, Bhargava, Rohit, Clark, Jennifer L., Deavers, Michael T., Jorns, Julie M., Khan, Ashraf, Cosar, Ediz F., Karabakhtsian, Rouzan G., Klein, Molly E., Pinto, Andre, Ali, Muhammad

“…Published data on combined breast and gynecologic [breast/gyn] surgical pathology fellowship training programs are limited. Our study aimed to survey the…”
Get full text

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients by Yau, Christina, van der Noordaa, Marieke, Shad, Sonal, de Croze, Diane, Hamy, Anne-Sophie, Laé, Marick, Reyal, Fabien, Sonke, Gabe S, Steenbruggen, Tessa G, van Seijen, Maartje, Wesseling, Jelle, del Monte-Millán, Maria, López-Tarruella, Sara, Albain, Kathy S., Asare, Smita M., Balassanian, Ron, Beckwith, Heather, Berry, Scott M., Berry, Donald A., Boughey, Judy C., Buxton, Meredith B., Chen, Yunn-Yi, Chen, Beiyun, Clark, Amy S., Clennell, Julia L., DeMichele, Angela M., Duan, Xiuzhen, Edmiston, Kirsten K., Ellis, Erin D., Esserman, Laura L., Euhus, David M., Fan, Fang, Feldman, Michael D, Han, Hyo S., Haugen, Patricia, Helsten, Teresa, Hylton, Nola M., Isaacs, Claudine, Kemmer, Kathleen, Khazai, Laila, Klein, Molly E., Krings, Gregor, Leyland-Jones, Brian, Liu, Minetta C., Lo, Shelly, Lu, Janice, Magliocco, Anthony, Melisko, Michelle E., Mhawech-Fauceglia, Paulette, Moulder, Stacy L., Murthy, Rashmi K., Nanda, Rita, Ocal, Idris T., Olopade, Olufunmilayo, Pambuccian, Stefan, Paoloni, Melissa, Park, John W., Perlmutter, Jane, Peterson, Garry, Rendi, Mara, Rugo, Hope S., Sams, Sharon, Sattar, Husain, Schwab, Richard B., Singhrao, Ruby, Steeg, Katherine, Stringer-Reasor, Erica, Symmans, W. Fraser, Tripathy, Debasish, Troxell, Megan L., van't Veer, Laura J., Venters, Sara J., Vinh, Tuyethoa, Viscusi, Rebecca K., Wallace, Anne M., Wei, Shi, Wilson, Amy, Yau, Christina, Zeck, Jay C., Boughey, Judy C, Goetz, Matthew P, Hoskin, Tanya, Gould, Rebekah, Edge, Stephen B, Abraham, Jean E, Bartlett, John M S, Caldas, Carlos, Dunn, Janet, Hayward, Larry, Provenzano, Elena, Mackintosh, Lorna, Fan, Fang, Schwensen, Kelsey, Sharma, Priyanka, DeMichele, Angela M, Cole, Kimberly, Pusztai, Lajos, Kim, Mi-Ok, van 't Veer, Laura J, Symmans, W Fraser

“…Previous studies have independently validated the prognostic relevance of residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from…”
Get full text

Real-Time Intraoperative Consultation Reporting in the Electronic Health Record by Klein, Molly E, Rudolf, Joseph W, Tarbunova, Maryna, Jorden, Tanya, Clark, Susanna R, Khalifa, Mahmoud A

“…Abstract Objectives We sought to make pathologists’ intraoperative consultation (IOC) results immediately available to the surgical team, other clinicians, and…”
Get full text

Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy: Recommendations From the I-SPY Pathology Working Group by Sahoo, Sunati, Krings, Gregor, Chen, Yunn-Yi, Carter, Jodi M, Chen, Beiyun, Guo, Hua, Hibshoosh, Hanina, Reisenbichler, Emily, Fan, Fang, Wei, Shi, Khazai, Laila, Balassanian, Ronald, Klein, Molly E, Shad, Sonal, Venters, Sara J, Borowsky, Alexander D, Symmans, W. Fraser, Ocal, I. Tolgay

“…* Context.--Neoadjuvant systemic therapy refers to the use of systemic agent(s) for malignancy prior to surgical treatment and has recently emerged as an…”
Get full text

Abstract PS4-09: Pathologic features of the inter-regimen biopsy predict response to neoadjuvant therapy in the I-SPY 2 TRIAL by Carter, Jodi M, Klein, Molly E, Venters, Sara J, Rabe, Kimmie, Ocal, I Tolgay, Singh, Kamaljeet, Wolf, Denise M, Sahoo, Sunati, Harada, Shuko, Khazai, Laila, Harigopal, Malini, Borowsky, Alexander D, Krings, Gregor, Balassanian, Ronald, Chen, Yunn-Yi, Cole, Kimberley, Shad, Sonal, Delson, Amy, Brown-Swigart, Lamorna, Esserman, Laura, van ‘t Veer, Laura, Symmans, W Fraser

“…Background: I-SPY 2 is a neoadjuvant platform trial open to patients with locally advanced, molecular high-risk breast cancer. In a concerted pursuit of…”
Get full text

Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial by Symmans, W Fraser, Yau, Christina, Chen, Yunn-Yi, Balassanian, Ron, Klein, Molly E, Pusztai, Lajos, Nanda, Rita, Parker, Barbara A, Datnow, Brian, Krings, Gregor, Wei, Shi, Feldman, Michael D, Duan, Xiuzhen, Chen, Beiyun, Sattar, Husain, Khazai, Laila, Zeck, Jay C, Sams, Sharon, Mhawech-Fauceglia, Paulette, Rendi, Mara, Sahoo, Sunati, Ocal, Idris Tolgay, Fan, Fang, LeBeau, Lauren Grasso, Vinh, Tuyethoa, Troxell, Megan L, Chien, A Jo, Wallace, Anne M, Forero-Torres, Andres, Ellis, Erin, Albain, Kathy S, Murthy, Rashmi K, Boughey, Judy C, Liu, Minetta C, Haley, Barbara B, Elias, Anthony D, Clark, Amy S, Kemmer, Kathleen, Isaacs, Claudine, Lang, Julie E, Han, Hyo S, Edmiston, Kirsten, Viscusi, Rebecca K, Northfelt, Donald W, Khan, Qamar J, Leyland-Jones, Brian, Venters, Sara J, Shad, Sonal, Matthews, Jeffrey B, Asare, Smita M, Buxton, Meredith, Asare, Adam L, Rugo, Hope S, Schwab, Richard B, Helsten, Teresa, Hylton, Nola M, van 't Veer, Laura, Perlmutter, Jane, DeMichele, Angela M, Yee, Douglas, Berry, Donald A, Esserman, Laura J

“…Residual cancer burden (RCB) distributions may improve the interpretation of efficacy in neoadjuvant breast cancer trials. To compare RCB distributions between…”
Get more information